1 new product(s) added recently

The ASAM Review Course in Addiction Medicine 2018 (20.5 CME)

5 (4 votes)

image

Overview

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Over 600 professionals attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

Learning Objectives

Upon completion, participants should be able to:

  1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

Additional Resources

Additional Board Exam Preparation resources and tools are also available.


  • Evaluation and Certificate - ASAM Review Course 2018

    Contains 2 Component(s), Medical Credits Offered

    CME Evaluation for the ASAM Review Course 2018

    Complete the course evaluation first and then claim credits. Attendees should claim only the credit commensurate with the extent of their participation in the activity.

  • Expert Panel Discussion (2.5 CME)

    Contains 5 Component(s), Medical Credits Offered

    Earn 2.5 AMA PRA Category 1 Credits while watching an expert panel reviews questions from the attendees of The ASAM Review Course in Addiction Medicine 2018.

    (2.5 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, an expert panel reviews questions from the attendees of The ASAM Review Course in Addiction Medicine 2018.

  • Session 1: Neurobiology of Addiction (.75 CME)

    Contains 4 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of The Neurobiology of Addiction likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Animal Models of Addiction, Neuropharmacology, Acetylcholine, Norepinephrine, Dopamine, Serotonin, GammaAminobutyric Acid (GABA), Glutamate and NMDA Receptors , Other Amino Acids and Peptides, Endogenous Opioids, Endocannabinoids, Cellular and Molecular Mechanism in Addiction (Including NeuroAdaptation, Epigenetic Phenomena, etc.), NeuroImaging of Addiction and Related Phenomena (Craving, Relapse, Recovery, etc.)

    Petros Levounis

    MD, MA, DFASAM

    Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he received an MA degree in sociology from Stanford before moving to New York City where he trained in psychiatry at Columbia University. He graduated from Columbia receiving the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University. From 2002 to 2013, he served as director of the Addiction Institute of New York.
    Dr. Levounis has written numerous articles and monographs; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by all major television networks. Dr. Levounis serves on the Board of Directors of the American Society of Addiction Medicine (ASAM) and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association. Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association. 

    Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “The Behavioral Addictions,” “Motivational Interviewing for Clinical Practice,” “Becoming Mindful,” and the “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. His books have been translated into German, Hungarian, Japanese, Portuguese, and Spanish. 

    Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

  • Session 10: Epidemiology (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Epidemiology likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Epidemiologic Associations and Interpretation, Biostatistics, Vital Statistics and Demography, Describing Data, Hypothesis Testing, MetaAnalysis, Measurements of Morbidity and Mortality, Incidence, Prevalence, and Initiation

  • Session 11: Tobacco (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Tobacco likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Nicotine and Tobacco, Management of Other Drug Intoxication and Withdrawal (Nicotine), Pharmacological Interventions for Tobacco Dependence.

    Abigail J. Herron

    DO, DFASAM, FAPA

    Abigail J. Herron, DO, is the Director of Psychiatry and the Director of the Fellowship in Addiction Medicine at the Institute for Family Health.  She is board certified in adult psychiatry, addiction psychiatry and addiction medicine, and is an Assistant Professor of Psychiatry at the Icahn School of Medicine at Mt. Sinai.  

    Dr. Herron is a fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine.  She graduated from Wesleyan University and the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.  Dr. Herron completed her psychiatry residency at St. Luke's and Roosevelt Hospitals, where she was also chief resident, and a clinical research fellowship in addiction psychiatry at Columbia University and the New York State Psychiatric Institute.  

    Her academic interests include integrated care, women’s health, and medical education.  She is the co-editor of the Addiction Casebook, and the editor-in-chief of ASAM’s Essentials of Addiction Medicine.  Dr. Herron is also in private practice in New York City. 

  • Session 12: Opioids (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Opioids likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Opioids (Opium, Heroin, Prescription Opioids), Management of Opioid Intoxication and Withdrawal, Pharmacological Interventions for Opioid Dependence

    Edwin A. Salsitz

    MD, DFASAM

    Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Assistant Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. 

    Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings,and is a mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. 

    Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.  Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.

  • Session 13: Prevention and Public Health (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of prevention and public health likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Primary Prevention, Secondary Prevention, Tertiary Prevention, Environmental Interventions to Reduce Alcohol, Tobacco and Other Drug Use, Prevention Programs, High Risk Populations, Educational Approaches, Community Organizational Approaches, Public Policy Approaches, Regulation of Supply, Demand Reduction.

    Sharon Stancliff

    MD, FAAFP

    Sharon Stancliff, M.D. is the Medical Director of the Harm Reduction Coalition She oversees SKOOP, which provides overdose prevention services both directly in New York City and through education and capacity building nationally and internationally. Dr. Stancliff also consults on drug related problems for the AIDS Institute, New York State Department of Health and for several international organizations. 

    Dr. Stancliff graduated from the School of Medicine at University of California at Davis, did her Family Practice residency at the University of Arizona and completed the AIDS Institute-sponsored Nicolas Rango HIV Clinical Scholars Program at Beth Israel Medical Center in New York City. She is board certified in Family Medicine, a Fellow of the American Academy of Family Practice, and certified by the American Board of Addiction Medicine. She serves as secretary for the New York Society of Addiction Medicine.

  • Session 14: Other Classes of Drugs (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Other Classes of Drugs likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Hallucinogens (LSD, Mescaline, Psilocybin, and Other Hallucinogens), Dissociatives (Phencyclidine, Ketamine, Dextromethorphan and Other Dissociatives), Inhalants (Nitrous Oxide, Hydrocarbons and Other Inhalants), Anabolic Steroids, Management of Other Drug Intoxication and Withdrawal (Phencyclidine, Hallucinogens, Dissociatives, Inhalants, Steroids, Pharmacologic Interventions for Other Drug Dependence, Pharmacological Interventions for NonSubstance Related Addictions.

    Erin A. Zerbo

    MD, FASAM

    Erin Zerbo, MD, FASAM is an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School, and the Associate Director of Medical Student Education. She will serve as Director of the Wellness Center at University Hospital when it opens in Fall 2015.

    She received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She continued in a psychiatry residency at New York University, where she served as chief resident during her PGY-IV year and received the Harold I. Kaplan Memorial Award for excellence in teaching and the Wendy Rives Memorial Award for compassion in working with the severely mentally ill. Following residency, she remained at NYU for a one-year fellowship in Addiction Psychiatry.

    Prior to her faculty position at Rutgers, Dr. Zerbo served as the Associate Director of the Consultation-Liaison Psychiatry Service at Bellevue Hospital and the Associate Director of the NYU Addiction Psychiatry fellowship.

    Dr. Zerbo's primary interest has always been the treatment of addiction in the context of public psychiatry. She is especially interested in the pharmacotherapy of substance use disorders among underserved populations, and in addressing systemic barriers to integrated and continuous care. Recent publications include a chapter entitled “Co-occurring Personality Disorders and Addiction" in The ASAM Principles of Addiction Medicine textbook, and an article accepted for publication in the Harvard Review of Psychiatry which explores how to improve attitudes of psychiatry residents toward patients with substance use disorders.

  • Session 15: Psychiatric Co-Morbidities (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Psychiatric Co-Morbidities likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Neuropsychological Dysfunction (Problems With Attention, Memory, Learning, Executive Function), Substance Induced Mental Disorders, Affective Disorders, Posttraumatic Stress Disorder, Other Anxiety Disorders, Psychotic Disorders, Attention Deficit/Hyperactivity Disorder, Eating Disorders, Personality Disorders.

    Richard K. Ries

    MD, DFASAM

    Richard K. Ries, MD, is Professor of Psychiatry, and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle, Washington and Director of the Addiction Treatment services at Harborview Medical Center in downtown Seattle. Dr. Ries received his undergraduate degree from Stanford, medical degree from Northwestern Medical School and completed his psychiatric residency at the University of Washington, Seattle, where he was Chief Resident. 

    Dr. Ries is board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine.  A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, he is on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health. 

    He has published numerous articles and abstracts on topics related to treatment of persons with severe mental illness, with special emphasis on those with co-existing problems with alcohol or drugs, and was the chair and co-chair of TIPS 9 and 42 on Treatment of Persons with Co-occurring  Addiction and Mental Disorders published by the national Center of Substance Abuse Treatment (CSAT).  He is senior editor of  the key reference text:  Principles of Addiction Medicine (edition V, 2014), published by the American Society of Addiction Medicine, and a noted expert in the  field of Addictions.

  • Session 16: Board Exam Preparation (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning about MOC as well as the structure, timing, and layout of the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: ABPM MOC, 2018 Addiction Medicine Exam Structure and Layout, Epidemiology, Ethics and the Law, Alcohol, Opioids, Prevention and Public Health, Pain and Addiction.

    Abigail J. Herron

    DO, DFASAM, FAPA

    Abigail J. Herron, DO, is the Director of Psychiatry and the Director of the Fellowship in Addiction Medicine at the Institute for Family Health.  She is board certified in adult psychiatry, addiction psychiatry and addiction medicine, and is an Assistant Professor of Psychiatry at the Icahn School of Medicine at Mt. Sinai.  

    Dr. Herron is a fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine.  She graduated from Wesleyan University and the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.  Dr. Herron completed her psychiatry residency at St. Luke's and Roosevelt Hospitals, where she was also chief resident, and a clinical research fellowship in addiction psychiatry at Columbia University and the New York State Psychiatric Institute.  

    Her academic interests include integrated care, women’s health, and medical education.  She is the co-editor of the Addiction Casebook, and the editor-in-chief of ASAM’s Essentials of Addiction Medicine.  Dr. Herron is also in private practice in New York City. 

    Erin A. Zerbo

    MD, FASAM

    Erin Zerbo, MD, FASAM is an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School, and the Associate Director of Medical Student Education. She will serve as Director of the Wellness Center at University Hospital when it opens in Fall 2015.

    She received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She continued in a psychiatry residency at New York University, where she served as chief resident during her PGY-IV year and received the Harold I. Kaplan Memorial Award for excellence in teaching and the Wendy Rives Memorial Award for compassion in working with the severely mentally ill. Following residency, she remained at NYU for a one-year fellowship in Addiction Psychiatry.

    Prior to her faculty position at Rutgers, Dr. Zerbo served as the Associate Director of the Consultation-Liaison Psychiatry Service at Bellevue Hospital and the Associate Director of the NYU Addiction Psychiatry fellowship.

    Dr. Zerbo's primary interest has always been the treatment of addiction in the context of public psychiatry. She is especially interested in the pharmacotherapy of substance use disorders among underserved populations, and in addressing systemic barriers to integrated and continuous care. Recent publications include a chapter entitled “Co-occurring Personality Disorders and Addiction" in The ASAM Principles of Addiction Medicine textbook, and an article accepted for publication in the Harvard Review of Psychiatry which explores how to improve attitudes of psychiatry residents toward patients with substance use disorders.

    Edwin A. Salsitz

    MD, DFASAM

    Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Assistant Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. 

    Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings,and is a mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. 

    Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.  Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.

    Adam Gordon

    MD, MPH, FACP, CMRO, DFASAM

    Adam Gordon, MD MPH FACP DFASAM CMRO is the Elbert F. and Marie Christensen Endowed Research Professor of Medicine and Psychiatry at the University of Utah School of Medicine and Chief of Addiction Medicine at the Salt Lake City VA Healthcare System. He is a board certified internal medicine (American Board of Internal Medicine) and addiction medicine physician (American Board of Addiction Medicine) and has received distinction in both fields as a Fellow in the American College of Physicians (FACP) and a Distinguished Fellow in the American Society of Addiction Medicine (DFASAM). Prior to moving to Salt Lake City in the Winter of 2017, he was a Professor of Medicine and Clinical and Translational Sciences and an Advisory Dean in Student Affairs at the University of Pittsburgh School of Medicine. He maintains an active internal medicine – addiction medicine practice and has been honored nationally for his community service and clinical activities.

    He has a 17-year track record of conducting clinical, health services, and implementation scienceresearch on the quality, equity, and efficiency of health care for vulnerable populations, including patients with opioid use and other substance disorders and/or who are homeless. Major themes of his current research include the identification and implementation of evidence-based care for patients with addiction disorders and understanding the intersection of pain syndromes, opioid misuse, and engagement into opioid use disorder treatment. He is a prior VA Health Services Research and Development Service Career Development Awardee. His research has been funded by the NIH, VA, AHRQ, PCORI, SAMHSA, among others. He has authored over 150 peer reviewed scientific papers, several books and book chapters, and hundreds of peer reviewed scholarly abstracts, presentations, and other work. He has been recognized with several national research awards for his research, including the Young Investigator of the Year from the Association for Medical Education and Research on Substance Abuse (AMERSA).

    His professional career has been noted for service to federal government, community initiatives, and mentoring. For example, he directs the Buprenorphine Initiative in the VA where he leads a national consult service to increase the implementation of medication treatment for opioid use disorder. He is the Director of the National Coordinating Center for the VA Office of Academic Affiliations Advanced Interdisciplinary Fellowship in Addiction Research and Treatment, where he coordinates educational activities for fellowship sites across the country. He serves as the Editor-in-Chief of Substance Abuse, the Board of Directors of the International Society of Addiction Journal Editors, and the Board of Directors of AMERSA. He has had leading positions with several organizations including American Society of Addiction Medicine (ASAM. Chair of Continuing Medical Education), Allegheny County Medical Society (President, Board of Directors), and Pennsylvania Medical Society (Board of Trustees).

    As a senior, tenured, faculty member, he is passionate about training the next generation of clinicians and clinical researchers. Apart from this advising of hundreds of medical students in his prior capacity as an Advisory Dean at the University of Pittsburgh, he has educated, trained, or mentored over 50 post-graduate scholars to be leaders in scholarly activities involving addiction treatment. His mentees have received research career development awards, large VA/NIH research grants, and local and national young investigator of the year awards. As a testament to his teaching and mentoring expertise, he was named as one of the inaugural VA Health Services Research and Development (HSR&D) National Mentor Network (MNet) mentors. In addition, he has received of research mentoring awards including from the University of Pittsburgh, the AMA, and AMERSA (2013 W. Anderson Spickard, Jr. Excellence in Mentorship Award).

    Adam lives with his wife, Margaret Conroy, MD MPH and children Lillian, Neil, and Martha in Salt Lake City, Utah. He enjoys gardening and tennis.

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The ASAM CME Committee and Reviewers Disclosure Listing

First Name Commercial Interests Compensation Received For what Role?
Timothy Brennan MD, MPH, FASAM None
Jeffrey DeVido MD Altria/Philip Morris Stock Inheritance
Paul Earley MD, DFASAM Alkermes, Inc; DynamiCare Health, Inc honoraria; Salary Speaker; VP of Medical Affairs 
James Finch MD, DFASAM None

Marc Fishman MD, DFASAM US World Meds; Alkermes consulting fee, travel; honoraria Consultant; Advisory board
David Galbis-Reig MD, DFASAM Ascension Wisconsin All Saints; Abbvie; Hospira; RespireRX Pharmaceuticals; Abbott Pharmaceuticals; Pfizer Bond Stock& Bond in Retirement IRA; Stock Options; Ownership Interests  Owner; Advisory board; PI; Consultant
Adam Gordon, MD, MPH None
Leslie Hayes, MD None
Abigail Herron DO, DFASAM None
Petros Levounis MD, MA, FASAM None
Carla Marienfeld MD None
Ricardo Restrepo MD, MPH, FASAM None
Richard Ries MD, DFASAM None
Edwin Salsitz MD, DFASAM None
Sharon Stancliff MD, FASAM None
Timothy Wiegand MD, FACMT, FAACT None
Erin Zerbo, MD None

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians: 

This Live activity, The 2018 ASAM Review Course in Addiction Medicine & Pre-Courses, with a beginning date of 07/25/2018, has been reviewed and is acceptable for up to 27.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Transitional Maintenance of Certification Program (Tmoc)

This course has been approved by The American Board of Addiction Medicine (ABAM).  Physicians enrolled in the Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 20.5 AMA PRA Category 1 Credits

American Psychological Association (APA)

The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

CME Committee Members

  • Catherine Friedman, MD, FASAM, Chair
  • R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM
  • Adam J. Gordon, MD, MPH, FACP, DFASAM
  • Zwaantje Hamming, FNP-C, CARN-AP
  • Noel Ilogu, MD, MRCP, FASAM
  • Herbert L. Malinoff, MD, FACP, DFASAM
  • Edwin A. Salsitz, MD, DFASAM

Staff - Sandy Metcalfe; Arlene Deverman, MA, CAE, CFRE; Marcia Jackson, PhD

CME Committee, Program Planning Committee and Faculty Disclosure Information

In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 20.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPM Maintenance of Certification (MOC)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 20.5 LLSA credits towards ABPM MOC Part II requirements.

ABAM Transitional Maintenance of Certification (tMOC)

This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 20.5 AMA PRA Category 1 Credit(s)™ for completing this course.

Upon completion, participants should be able to:

  1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting.
  2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals.
  3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders.
  4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient.
  5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse.

The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

  • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
  • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
  • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients